Radiolabeled prostate specific membrane antigen inhibitors
Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity: The invention also provides pharmaceutical compositions of a complex of a radionuclide and a Formula I compound or a Formula II compound and methods of using the radionuclide complex of a Formula I compound or a...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.03.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity: The invention also provides pharmaceutical compositions of a complex of a radionuclide and a Formula I compound or a Formula II compound and methods of using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity. |
---|---|
Bibliography: | Application Number: AU20120294639 |